These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29849724)

  • 1. Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis.
    Dong T; Wang J; Ma X; Ma R; Wen J; Chen N; Xie Q
    Evid Based Complement Alternat Med; 2018; 2018():6949348. PubMed ID: 29849724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
    Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis.
    Lu X; Zhang L; Wang J; Liu H; Li H; Zhou H; Wu R; Yang Y; Wen J; Wei S; Zhou X; Zhao Y; Xiao X
    Front Pharmacol; 2018; 9():810. PubMed ID: 30140225
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.
    Guo H; Zhu M; Yu R; Li X; Zhao Q
    Front Cardiovasc Med; 2023; 10():1255940. PubMed ID: 38054101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
    Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Traditional Chinese Medicine Cutaneous Regions Therapy as adjuvant treatment of chronic heart failure: A systematic review and meta-analysis.
    Li M; Li H; Liu H; Lai X; Xing W; Shang J
    Heliyon; 2023 May; 9(5):e16012. PubMed ID: 37206004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.
    Zhou Z; Shen W; Yu L; Xu C; Wu Q
    J Ethnopharmacol; 2016 Dec; 194():1130-1139. PubMed ID: 27847338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis.
    Wang M; Shan Y; Sun W; Han J; Tong H; Fan M; Chen J; Yu P; Shen L; Chen X
    Front Pharmacol; 2021; 12():751050. PubMed ID: 34795585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Network Meta-analysis of Chinese patent medicine in treatment of heart failure with preserved ejection fraction].
    Tian J; Xu BR; Xing ZY; Qiu BY; Si CY; Zhu MJ; Wang YX
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):819-835. PubMed ID: 38621886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
    Mei J; Xu H; Xu FQ; Ju JQ
    Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
    Wen J; Ma X; Zhang L; Lu X; Yang Y; Wang J; Zhao Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13580. PubMed ID: 30572460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Shengmai Injection for Chronic Heart Failure: A Systematic Review of Randomized Controlled Trials.
    Wang Y; Zhou X; Chen X; Wang F; Zhu W; Yan D; Shang H
    Evid Based Complement Alternat Med; 2020; 2020():9571627. PubMed ID: 32655670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Network Meta-analysis of six Chinese patent medicines for replenishing Qi and activating blood in treatment of chronic heart failure].
    Park YS; Wang W; Li YD; Liu K
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4221-4237. PubMed ID: 36046913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.
    Guo H; Li X; Zhu M
    Front Pharmacol; 2022; 13():955146. PubMed ID: 36071856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Meta-analysis of efficacy and safety of Shexiang Tongxin Dripping Pills combined with conventional therapy of coronary heart disease].
    Pan J; Zhou JM; Wang XM; Zuo KN; Wang ZH; Lu SQ; Wang W; Zhu WT
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2325-2332. PubMed ID: 34047137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Shi L; Xie Y; Liao X; Chai Y; Luo Y
    BMC Complement Altern Med; 2015 Nov; 15():418. PubMed ID: 26603978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yiqi Fumai Injection as an Adjuvant Therapy in Treating Chronic Heart Failure: A Meta-Analysis of 33 Randomized Controlled Trials.
    Nie H; Li S; Liu M; Zhu W; Zhou X; Yan D
    Evid Based Complement Alternat Med; 2020; 2020():1876080. PubMed ID: 32922505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety evaluation of Shenmai injections for dilated cardiomyopathy: A systematic review and meta-analysis of randomised controlled trials.
    Wang Y; Liu Q; Kong Y; Zhong G; Wang D
    Phytomedicine; 2023 Feb; 110():154630. PubMed ID: 36608499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
    Shi L; Huang L; Yin E; Deng J; Du X
    PLoS One; 2023; 18(12):e0295344. PubMed ID: 38048301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Xinbao Pill in Chronic Heart Failure.
    Wang Y; Liu Y; Liu Z; Cheng Y; Wang D
    Front Pharmacol; 2022; 13():846867. PubMed ID: 35308242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.